n(6)-benzyl-cyclic adenosine 5'-monophosphate has been researched along with Cancer of Prostate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Misra, UK; Pizzo, SV | 1 |
1 other study(ies) available for n(6)-benzyl-cyclic adenosine 5'-monophosphate and Cancer of Prostate
Article | Year |
---|---|
Upregulation of mTORC2 activation by the selective agonist of EPAC, 8-CPT-2Me-cAMP, in prostate cancer cells: assembly of a multiprotein signaling complex.
Topics: Adaptor Proteins, Signal Transducing; Carrier Proteins; Cell Line, Tumor; Chromones; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Endoplasmic Reticulum Chaperone BiP; Gene Silencing; Guanine Nucleotide Exchange Factors; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Models, Biological; Morpholines; Multiprotein Complexes; Phosphorylation; Prostatic Neoplasms; Protein Multimerization; Proteins; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases; RNA-Binding Proteins; Signal Transduction; Sirolimus; Thionucleotides; TOR Serine-Threonine Kinases; Up-Regulation | 2012 |